XML 39 R7.htm IDEA: XBRL DOCUMENT v3.20.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY - USD ($)
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance at Dec. 31, 2018 $ 5,995,257 $ (32,345,002) $ 24,326,778 $ 213,297,897 $ 486,543 $ 211,761,473
Increase (decrease) in shareholders' equity            
Net Income (Loss)       6,468,099   6,468,099
Stock Repurchase   (4,125,194)       (4,125,194)
Exercise of Stock Options 12,957   (316,272)     (303,315)
Stock Issuance 4,779   267,352     272,131
Stock Compensation Expense from Restricted Stock Grants and Equity Classified Stock Options     539,470     539,470
Cash Dividends       (534,896)   (534,896)
Other Comprehensive Loss, Net of Income Tax         (128,814) (128,814)
Balance at Mar. 31, 2019 6,012,993 (36,470,196) 24,817,328 219,231,100 357,729 213,948,954
Balance at Dec. 31, 2018 5,995,257 (32,345,002) 24,326,778 213,297,897 486,543 211,761,473
Increase (decrease) in shareholders' equity            
Stock Repurchase           (41,100,000)
Balance at Dec. 31, 2019 6,017,218 (73,440,714) 26,689,795 326,073,199 73,924 285,413,422
Increase (decrease) in shareholders' equity            
Net Income (Loss)       (12,261,859)   (12,261,859)
Stock Repurchase   (3,914,614)       (3,914,614)
Equity Component of Convertible Debt     5,247,550     5,247,550
Vested Restricted Stock and Performance Shares 23,892   (561,973)     (538,081)
Stock Issuance 3,861   237,280     241,141
Stock Compensation Expense from Restricted Stock Grants and Equity Classified Stock Options     577,964     577,964
Cash Dividends       (1,184,653)   (1,184,653)
Other Comprehensive Loss, Net of Income Tax         (1,373,285) (1,373,285)
Balance at Mar. 31, 2020 $ 6,044,971 $ (77,355,328) $ 32,190,616 $ 312,626,687 $ (1,299,361) $ 272,207,585